Real-Life Clinical Effectiveness of Razumab® (World’s First Biosimilar Ranibizumab) in Wet Age- Related Macular Degeneration, Diabetic Macular Edema, and Retinal Vein Occlusion: A Retrospective Pooled Analysis

Unknown, Sharma S, Khan MA, Unknown

Open source

DOI
10.19070/2332-290x-1800076
Published
2018-06-13
Container
International Journal of Ophthalmology & Eye Science
Publisher
SciDoc Publishers LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.19070/2332-290x-1800076,
  title = {Real-Life Clinical Effectiveness of Razumab® (World’s First Biosimilar Ranibizumab) in Wet Age- Related Macular Degeneration, Diabetic Macular Edema, and Retinal Vein Occlusion: A Retrospective Pooled Analysis},
  author = {Unknown and Sharma S and Khan MA and Unknown},
  year = {2018},
  journal = {International Journal of Ophthalmology \& Eye Science},
  doi = {10.19070/2332-290x-1800076},
  url = {https://doi.org/10.19070/2332-290x-1800076}
}

RIS

TY  - JOUR
TI  - Real-Life Clinical Effectiveness of Razumab® (World’s First Biosimilar Ranibizumab) in Wet Age- Related Macular Degeneration, Diabetic Macular Edema, and Retinal Vein Occlusion: A Retrospective Pooled Analysis
AU  - Unknown
AU  - Sharma S
AU  - Khan MA
AU  - Unknown
PY  - 2018
JO  - International Journal of Ophthalmology & Eye Science
DO  - 10.19070/2332-290x-1800076
UR  - https://doi.org/10.19070/2332-290x-1800076
ER  - 

APA

Unknown, S, S., MA, K., & Unknown (2018). Real-Life Clinical Effectiveness of Razumab® (World’s First Biosimilar Ranibizumab) in Wet Age- Related Macular Degeneration, Diabetic Macular Edema, and Retinal Vein Occlusion: A Retrospective Pooled Analysis. International Journal of Ophthalmology & Eye Science. https://doi.org/10.19070/2332-290x-1800076

Source records